Technical Articles

Immuno-Oncology

The application of FITC-labeled NKG2D/CD314 Fc chimeric protein in immuno-oncology research

2026-04-28

Natural killer cells are currently at the forefront of many immunotherapy strategies, and new methods are being developed to fully harness the anti-tumor potential of NK cells. NK cells play a critical role in tumor immunity and are increasingly becoming a cutting-edge area in immunotherapy strategies.

View details

Cancer
NKG2D/CD314
Immuno-Oncology
Tumor Microenvironment

Total 1

Go to